FFCP PHASE1:Mm9::chr15:62013300..62013316,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=NA|HGNC=|MCL_coexpression_id=48|UniProt=NA|association_with_transcript=NA|description=CAGE_peak_at_chr15:62013300..62013316,+|id=chr15:62013300..62013316,+|ontology_enrichment_celltype=CL:0000988!7.18e-12!32;CL:0002032!7.18e-12!32;CL:0000037!7.18e-12!32;CL:0000566!7.18e-12!32;CL:0000837!7.18e-12!32;CL:0002320!9.44e-08!46;CL:0000134!9.44e-08!46;CL:0000049!1.45e-07!19|ontology_enrichment_celltype_v019_2=CL:0000945,2.74e-44,1;CL:0000236,2.74e-44,1;CL:0000826,2.74e-44,1;CL:0000625,7.47e-44,1;CL:0000838,1.13e-15,12;CL:0000542,1.42e-14,13;CL:0000051,1.42e-14,13;CL:0000738,1.86e-11,17;CL:0002087,1.86e-11,17;CL:0002031,3.41e-08,25|ontology_enrichment_disease=|ontology_enrichment_disease_v019_2=|ontology_enrichment_uberon=UBERON:0002384!9.44e-08!46;UBERON:0002390!2.03e-07!45;UBERON:0003061!2.03e-07!45;UBERON:0002193!7.40e-07!48|ontology_enrichment_uberon_v019_2=|phase1_expression=0,0,0,0,0,0,0,0.258246646883153,0,0.70219357896598,0,0,0,0,0,0,0,0.630924330716475,0.274228867211478,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5.5368259999053,0,1.00828139742739,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.479260498023681,0.599902730993408,0.254140454146129,0,0,0,0,0,0,0,0,0.124406970610093,0,0,0,0,0,0,0.0680364991513279,0,0,0,0,0,0,0,0,0,0,0,0,0.257347907114715,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.159454768657487,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.136694227721025,0,0.509935289981566,0.139951452323658,0.138199973804424,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.202725215290164,0,0.129920822977795,0.179026695667481,0,0,0,0,0,0.100826185136841,0,0.0962118416403295,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0|short_description=p@chr15:62013300..62013316,+}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |||
|HGNC= | |||
|MCL_coexpression_id=48 | |||
|TSSclassifier=NA | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr15:62013300..62013316,+ | |||
|description=CAGE_peak_at_chr15:62013300..62013316,+ | |||
|id=chr15:62013300..62013316,+ | |||
|ontology_enrichment_celltype=CL:0000988!7.18e-12!32;CL:0002032!7.18e-12!32;CL:0000037!7.18e-12!32;CL:0000566!7.18e-12!32;CL:0000837!7.18e-12!32;CL:0002320!9.44e-08!46;CL:0000134!9.44e-08!46;CL:0000049!1.45e-07!19 | |||
|ontology_enrichment_celltype_v019_2=CL:0000945,2.74e-44,1;CL:0000236,2.74e-44,1;CL:0000826,2.74e-44,1;CL:0000625,7.47e-44,1;CL:0000838,1.13e-15,12;CL:0000542,1.42e-14,13;CL:0000051,1.42e-14,13;CL:0000738,1.86e-11,17;CL:0002087,1.86e-11,17;CL:0002031,3.41e-08,25 | |||
|ontology_enrichment_disease= | |||
|ontology_enrichment_disease_v019_2= | |||
|ontology_enrichment_uberon=UBERON:0002384!9.44e-08!46;UBERON:0002390!2.03e-07!45;UBERON:0003061!2.03e-07!45;UBERON:0002193!7.40e-07!48 | |||
|ontology_enrichment_uberon_v019_2= | |||
|phase1_expression=0,0,0,0,0,0,0,0.258246646883153,0,0.70219357896598,0,0,0,0,0,0,0,0.630924330716475,0.274228867211478,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5.5368259999053,0,1.00828139742739,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.479260498023681,0.599902730993408,0.254140454146129,0,0,0,0,0,0,0,0,0.124406970610093,0,0,0,0,0,0,0.0680364991513279,0,0,0,0,0,0,0,0,0,0,0,0,0.257347907114715,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.159454768657487,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.136694227721025,0,0.509935289981566,0.139951452323658,0.138199973804424,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.202725215290164,0,0.129920822977795,0.179026695667481,0,0,0,0,0,0.100826185136841,0,0.0962118416403295,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p@chr15:62013300..62013316,+ | |||
}} |
Latest revision as of 08:44, 5 August 2015
Short description: | p@chr15:62013300..62013316, + |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr15:62013300..62013316, + |
Coexpression cluster: | MCL_coexpression_mm9:48 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
lymphocyte of B lineage | 2.74e-44 | 1 |
B cell | 2.74e-44 | 1 |
pro-B cell | 2.74e-44 | 1 |
CD8-positive, alpha-beta T cell | 7.47e-44 | 1 |
lymphoid lineage restricted progenitor cell | 1.13e-15 | 12 |
lymphocyte | 1.42e-14 | 13 |
common lymphoid progenitor | 1.42e-14 | 13 |
leukocyte | 1.86e-11 | 17 |
nongranular leukocyte | 1.86e-11 | 17 |
hematopoietic lineage restricted progenitor cell | 3.41e-08 | 25 |